HELP THEM overcome the barriers of facial and truncal acne.

Facial acne is only half the story.

52%

OF PATIENTS WITH FACIAL ACNE
ALSO HAVE TRUNCAL ACNE1

Patients with truncal acne often suffer from self-consciousness and social withdrawal.2 They also feel embarrassed by the acne on their trunk, but still focus more on their facial acne when speaking with their dermatology providers.1,2

MOST patients want treatment.1

78%

OF PATIENTS PRESENT WITH
FACIAL ACNE BUT ALSO
WANT TREATMENT FOR THEIR
TRUNCAL ACNE1

Image

Now with AKLIEF® (trifarotene) Cream, 0.005% YOU CAN HELP CHANGE THEIR STORY.

References: 1. Del Rosso JQ, Bikowski JB, Baum E, et al. A closer look at truncal acne vulgaris: Prevalence, severity, and clinical significance. J Drugs Dermatol. 2007;6(6):597-600. 2. Mandy, SH. Chest and back acne: A retrospective review. Advances in Therapy. 1995;12(6):321-332.

IMPORTANT SAFETY INFORMATION

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Please see full Important Safety Information below.

Scroll to ISI